AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.240
-0.030 (-0.92%)
Nov 20, 2024, 4:00 PM EST - Market closed
AC Immune Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 40.97 | 14.8 | 3.94 | - | 15.43 | 110.46 | Upgrade
|
| Revenue Growth (YoY) | 4097200.00% | 276.14% | - | - | -86.03% | 1498.03% | Upgrade
|
| Cost of Revenue | 61.43 | 54.61 | 60.34 | 62.28 | 59.49 | 50.43 | Upgrade
|
| Gross Profit | -20.46 | -39.81 | -56.4 | -62.28 | -44.06 | 60.02 | Upgrade
|
| Selling, General & Admin | 17.33 | 15.31 | 15.79 | 17.91 | 18.56 | 16.06 | Upgrade
|
| Other Operating Expenses | -0.48 | -1.49 | -1.34 | -1.18 | -1.35 | -0.57 | Upgrade
|
| Operating Expenses | 16.85 | 13.82 | 14.45 | 16.73 | 17.2 | 15.49 | Upgrade
|
| Operating Income | -37.3 | -53.62 | -70.85 | -79.01 | -61.26 | 44.54 | Upgrade
|
| Interest Expense | -0.13 | -0.18 | -0.36 | -0.58 | -0.18 | -1.93 | Upgrade
|
| Interest & Investment Income | 2.6 | 1.04 | 0.07 | 6.49 | 0.08 | 0.3 | Upgrade
|
| Currency Exchange Gain (Loss) | -5.03 | -1.47 | 0.39 | 0.11 | -0.56 | -2.01 | Upgrade
|
| EBT Excluding Unusual Items | -39.86 | -54.22 | -70.74 | -72.99 | -61.92 | 40.9 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 4.54 | Upgrade
|
| Pretax Income | -39.86 | -54.22 | -70.74 | -72.99 | -61.92 | 45.44 | Upgrade
|
| Income Tax Expense | 0 | 0.01 | 0.01 | 0 | - | - | Upgrade
|
| Net Income | -39.86 | -54.23 | -70.75 | -73 | -61.92 | 45.44 | Upgrade
|
| Net Income to Common | -39.86 | -54.23 | -70.75 | -73 | -61.92 | 45.44 | Upgrade
|
| Shares Outstanding (Basic) | 96 | 85 | 84 | 75 | 72 | 71 | Upgrade
|
| Shares Outstanding (Diluted) | 96 | 85 | 84 | 75 | 72 | 71 | Upgrade
|
| Shares Change (YoY) | 14.86% | 1.36% | 11.48% | 4.24% | 1.12% | 14.98% | Upgrade
|
| EPS (Basic) | -0.41 | -0.64 | -0.85 | -0.97 | -0.86 | 0.64 | Upgrade
|
| EPS (Diluted) | -0.41 | -0.64 | -0.85 | -0.97 | -0.86 | 0.64 | Upgrade
|
| Free Cash Flow | 43.07 | -61.21 | -74.81 | -68.32 | -61.22 | 53.34 | Upgrade
|
| Free Cash Flow Per Share | 0.45 | -0.72 | -0.90 | -0.91 | -0.85 | 0.75 | Upgrade
|
| Gross Margin | -49.93% | -268.93% | - | - | -285.50% | 54.34% | Upgrade
|
| Operating Margin | -91.04% | -362.30% | -1800.43% | - | -396.99% | 40.32% | Upgrade
|
| Profit Margin | -97.29% | -366.41% | -1798.04% | - | -401.28% | 41.14% | Upgrade
|
| Free Cash Flow Margin | 105.11% | -413.55% | -1901.07% | - | -396.75% | 48.29% | Upgrade
|
| EBITDA | -35.76 | -51.95 | -69.05 | -77.11 | -59.73 | 45.81 | Upgrade
|
| EBITDA Margin | -87.27% | - | - | - | - | 41.47% | Upgrade
|
| D&A For EBITDA | 1.54 | 1.67 | 1.79 | 1.9 | 1.54 | 1.27 | Upgrade
|
| EBIT | -37.3 | -53.62 | -70.85 | -79.01 | -61.26 | 44.54 | Upgrade
|
| EBIT Margin | -91.04% | - | - | - | - | 40.32% | Upgrade
|
| Revenue as Reported | 40.97 | 14.8 | 3.94 | - | 15.43 | 110.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.